Noradrenaline (Biomed)

Држава: Нови Зеланд

Језик: Енглески

Извор: Medsafe (Medicines Safety Authority)

Активни састојак:

Noradrenaline acid tartrate monohydrate 0.239 mg/mL equivalent to 0.12 mg/mL noradrenaline base;  

Доступно од:

Biomed Limited

INN (Међународно име):

Noradrenaline acid tartrate monohydrate 0.239 g/L (equivalent to 0.12 g/L noradrenaline base)

Дозирање:

0.12 mg/mL

Фармацеутски облик:

Solution for infusion

Састав:

Active: Noradrenaline acid tartrate monohydrate 0.239 mg/mL equivalent to 0.12 mg/mL noradrenaline base   Excipient: Glucose Sodium metabisulfite Water for injection

Јединице у пакету:

Bag, plastic, Propyflex non-PVC flexible, 100 mL

Класа:

Prescription

Тип рецептора:

Prescription

Произведен од:

Cambrex Profarmaco Milano Srl

Терапеутске индикације:

For the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

Резиме производа:

Package - Contents - Shelf Life: Bag, plastic, flexible non-PVC polypropylene IV bag with foil overwrap - 100 mL - 12 months unopened stored at or below 25°C. Do not refrigerate or freeze.

Датум одобрења:

2010-10-15

Карактеристике производа

NEW ZEALAND DATA SHEET
NORADRENALINE (BIOMED) 0.06 MG/ML, 0.1 MG/ML, 0.12 MG/ML, 0.16 MG/ML
SOLUTION FOR INFUSION
Page 1 of 7
1
PRODUCT NAME
Noradrenaline 0.06 mg/mL Solution for infusion
Noradrenaline 0.1 mg/mL Solution for infusion
Noradrenaline 0.12 mg/mL Solution for infusion
Noradrenaline 0.16 mg/mL Solution for infusion
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
All strengths indicated above relate to noradrenaline base, which is
added as noradrenaline
acid tartrate monohydrate.
All strengths contain sodium metabisulphite 0.2 mg/mL as an
antioxidant and glucose 5% for
tonicity.
For the full list of excipients, see Section 6.1.
3
PHARMACEUTICAL FORM
Noradrenaline is a sterile solution containing noradrenaline acid
tartrate available in a range
of ready to use strengths in flexible bags and syringes.
The pH range of the infusions is 3.0 – 4.6.
4 CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For
the
restoration
of
blood
pressure
in
certain
acute
hypotensive
states
(e.g.
phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal
anaesthesia, myocardial
infarction, septicaemia, blood transfusion, and drug reactions).
As an adjunct in the treatment of cardiac arrest. To restore and
maintain an adequate blood
pressure after an effective heartbeat and ventilation have been
established by other means.
4.2
DOSE AND METHOD OF ADMINISTRATION
Noradrenaline is intended for use undiluted. It contains no
antimicrobial preservatives.
Discoloured solutions or those containing a precipitate should not be
used.
Avoid contact with iron salts, alkalis, or oxidising agents.
RESTORATION OF BLOOD PRESSURE IN ACUTE HYPOTENSIVE STATES
Blood
volume
depletion
should
always
be
corrected
as fully
as
possible
before
any
vasopressor is administered. When, as an emergency measure,
intra-aortic pressures must
be maintained to prevent cerebral or coronary artery ischaemia,
noradrenaline can be
administered before and concurrently with blood volume replacement.
Administer by slow intravenous infusion, observing the response to an
initia